Go Pro
→ Forget SpaceX, this is Elon’s Next Breakthrough (From Brownstone Research) (Ad)tc pixel Free FC Stock Alerts

Franklin Covey (FC) Financials

Franklin Covey logo
$20.56 -0.41 (-1.96%)
Closing price 07/13/2026 03:59 PM Eastern
Extended Trading
$20.50 -0.06 (-0.28%)
As of 07/13/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Franklin Covey

Annual Income Statements for Franklin Covey

This table shows Franklin Covey's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 8/31/2015 8/31/2016 8/31/2017 8/31/2018 8/31/2019 8/31/2020 8/31/2021 8/31/2022 8/31/2023 8/31/2024 8/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 11 277 -7.17 -5.89 -1.02 -9.44 14 17 17 24 2.80
Consolidated Net Income / (Loss)		 11 7.02 -7.17 -5.89 -1.02 -9.44 14 18 18 23 3.07
Net Income / (Loss) Continuing Operations		 11 277 -7.17 -5.89 -1.02 -9.44 14 18 18 23 3.07
Total Pre-Tax Income 		17 12 -11 -5.52 0.59 0.80 6.08 22 26 33 6.07
Total Operating Income		 20 14 -8.88 -3.37 2.66 3.06 8.10 24 26 33 5.70
Total Gross Profit		 138 270 123 148 159 145 173 202 213 221 204
Total Revenue		 210 400 185 210 225 198 224 263 281 287 267
Operating Revenue		 210 400 185 210 225 198 224 263 281 287 267
Total Cost of Revenue		 72 130 63 61 66 53 51 61 67 66 63
Operating Cost of Revenue		 72 130 63 61 66 53 51 61 67 66 63
Total Operating Expenses		 119 -14 132 152 157 142 165 178 187 188 198
Selling, General & Admin Expense		 109 114 121 138 141 130 154 168 178 176 183
Depreciation Expense		 4.14 3.68 3.88 5.16 6.36 6.66 6.19 4.90 4.27 3.91 4.07
Amortization Expense		 3.73 3.26 3.54 5.37 4.98 4.61 5.01 5.27 4.34 4.25 4.39
Impairment Charge		 1.30 - - - - - - 0.00 0.00 0.93 0.00
Restructuring Charge		 0.59 0.78 1.48 0.00 0.00 1.64 - 0.00 0.57 3.01 6.72
Total Other Income / (Expense), net		 -2.12 -1.94 -2.03 -2.15 -2.06 -2.26 -2.03 -1.61 -0.49 0.00 0.36
Interest Expense		 2.14 2.26 2.41 2.68 2.36 2.32 2.10 1.68 1.58 1.12 0.57
Interest & Investment Income		 0.38 0.12 0.22 0.10 0.04 0.06 0.07 0.07 1.09 1.12 0.93
Income Tax Expense		 6.30 4.90 -3.74 0.37 1.62 10 -7.55 3.63 8.09 9.64 3.00
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - - - - -0.07 1.25 0.45 -0.22 0.26
Basic Earnings per Share		 $0.66 $0.47 ($0.52) ($0.43) ($0.07) ($0.68) $0.97 $1.30 $1.30 $1.78 $0.24
Weighted Average Basic Shares Outstanding		 16.74M 14.94M 13.82M 13.85M 13.95M 13.89M 14.09M 14.15M 13.64M 13.17M 12.93M
Diluted Earnings per Share		 $0.66 $0.47 ($0.52) ($0.43) ($0.07) ($0.68) $0.96 $1.27 $1.24 $1.74 $0.24
Weighted Average Diluted Shares Outstanding		 16.92M 15.08M 13.82M 13.85M 13.95M 13.89M 14.14M 14.56M 14.30M 13.47M 13.05M
Weighted Average Basic & Diluted Shares Outstanding		 16.80M 14.90M 13.82M 13.85M 13.95M 13.89M 14.29M 13.90M 13.43M 13.18M 12.16M

Quarterly Income Statements for Franklin Covey

This table shows Franklin Covey's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q2 2026 Q3 2026
Period end date 8/31/2023 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 2/28/2026 5/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 6.49 4.90 0.74 5.55 12 0.98 -1.12 -1.26 4.20 -1.91 3.08
Consolidated Net Income / (Loss)		 6.81 4.85 0.87 5.72 12 1.18 -1.08 -1.41 4.37 -1.98 3.09
Net Income / (Loss) Continuing Operations		 6.81 4.85 0.87 5.72 12 1.18 -1.08 -1.41 4.37 -1.98 3.09
Total Pre-Tax Income 		10 5.28 1.42 8.36 18 1.59 -1.35 -2.13 7.96 -2.06 4.17
Total Operating Income		 11 5.33 1.44 8.34 18 1.48 -1.46 -2.20 7.89 -2.00 4.20
Total Gross Profit		 59 52 47 56 66 53 46 51 54 45 50
Total Revenue		 78 68 61 73 84 69 60 67 71 60 68
Operating Revenue		 78 68 61 73 84 69 60 67 71 60 68
Total Cost of Revenue		 19 16 14 17 18 16 14 16 17 14 18
Operating Cost of Revenue		 19 16 14 17 18 16 14 16 17 14 18
Total Operating Expenses		 49 47 45 48 48 51 47 54 46 47 46
Selling, General & Admin Expense		 46 44 41 45 45 47 45 46 44 43 43
Depreciation Expense		 1.14 1.09 0.91 0.99 0.91 0.95 1.02 1.01 1.09 1.14 1.19
Amortization Expense		 1.07 1.07 1.07 1.06 1.04 1.10 1.10 1.10 1.10 0.67 0.61
Other Operating Expenses / (Income)		 - - - - - - 0.00 0.44 - 0.46 0.14
Restructuring Charge		 - 0.58 1.73 0.70 - 1.98 0.00 4.74 - 1.51 0.70
Total Other Income / (Expense), net		 -0.12 -0.05 -0.03 0.02 0.06 0.11 0.11 0.08 0.07 -0.06 -0.03
Interest Expense		 0.41 0.34 0.33 0.25 0.20 0.18 0.16 0.14 0.10 0.09 0.05
Interest & Investment Income		 0.29 0.29 0.30 0.27 0.27 0.29 0.26 0.21 0.16 0.03 0.02
Income Tax Expense		 3.63 0.43 0.54 2.64 6.04 0.41 -0.27 -0.72 3.58 -0.08 1.08
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 0.32 -0.05 0.14 0.18 -0.48 0.20 0.04 -0.15 0.17 -0.08 0.01
Basic Earnings per Share		 $0.50 $0.37 $0.07 $0.43 $0.91 $0.09 ($0.08) ($0.11) $0.34 ($0.17) $0.27
Weighted Average Basic Shares Outstanding		 13.64M 13.24M 13.26M 13.16M 13.17M 13.09M 13.10M 12.89M 12.93M 11.42M 11.26M
Diluted Earnings per Share		 $0.48 $0.36 $0.06 $0.43 $0.89 $0.09 ($0.08) ($0.11) $0.34 ($0.17) $0.27
Weighted Average Diluted Shares Outstanding		 14.30M 13.64M 13.48M 13.38M 13.47M 13.27M 13.10M 12.89M 13.05M 11.42M 11.45M
Weighted Average Basic & Diluted Shares Outstanding		 13.43M 13.29M 13.27M 13.09M 13.18M 11.55M 12.99M 12.64M 12.16M 11.27M 11.29M

Annual Cash Flow Statements for Franklin Covey

This table details how cash moves in and out of Franklin Covey's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 8/31/2015 8/31/2016 8/31/2017 8/31/2018 8/31/2019 8/31/2020 8/31/2021 8/31/2022 8/31/2023 8/31/2024 8/31/2025
Net Change in Cash & Equivalents		 5.75 -5.78 -1.53 1.23 18 -0.56 20 13 -22 10 -17
Net Cash From Operating Activities		 26 33 17 17 30 28 46 52 36 60 29
Net Cash From Continuing Operating Activities		 26 33 17 17 30 28 46 52 36 60 29
Net Income / (Loss) Continuing Operations		 11 7.02 -7.17 -5.89 -1.02 -9.44 14 18 18 23 3.07
Consolidated Net Income / (Loss)		 11 7.02 -7.17 -5.89 -1.02 -9.44 14 18 18 23 3.07
Depreciation Expense		 7.88 6.94 7.44 11 11 11 11 10 8.61 8.15 8.46
Amortization Expense		 4.09 3.87 3.75 5.28 4.95 4.28 4.45 4.27 3.92 3.93 5.05
Non-Cash Adjustments To Reconcile Net Income		 3.70 3.17 3.49 2.85 4.79 -0.57 8.62 8.29 13 11 5.81
Changes in Operating Assets and Liabilities, net		 -0.60 12 9.85 4.10 10 22 8.29 11 -7.09 14 6.60
Net Cash From Investing Activities		 -4.87 -6.23 -22 -11 -6.87 -12 -14 -5.33 -14 -11 -17
Net Cash From Continuing Investing Activities		 -4.87 -6.23 -22 -11 -6.87 -12 -14 -5.33 -14 -11 -17
Purchase of Property, Plant & Equipment		 -2.45 -3.99 -7.19 -6.53 -4.15 -4.18 -1.60 -3.18 -4.52 -3.69 -8.25
Acquisitions		 -0.26 0.00 -8.02 -1.11 -0.03 0.00 -10 0.00 0.00 -0.75 -1.07
Other Investing Activities, net		 -2.17 -2.24 -6.47 -3.00 -2.69 -7.68 -2.50 -2.15 -9.04 -6.87 -7.56
Net Cash From Financing Activities		 -15 -33 3.13 -4.68 -5.93 -17 -11 -33 -44 -39 -29
Net Cash From Continuing Financing Activities		 -15 -33 3.13 -4.68 -5.93 -17 -11 -33 -44 -39 -29
Repayment of Debt		 -1.30 -49 -37 -95 -109 -22 -7.60 -8.72 -17 -9.37 -3.95
Repurchase of Common Equity		 -14 -44 -5.43 -2.01 -0.01 -14 -2.97 -24 -36 -31 -26
Issuance of Debt		 - 61 44 93 102 20 0.00 0.00 7.50 0.00 0.00
Issuance of Common Equity		 0.69 0.68 0.68 0.81 0.98 1.05 1.07 1.34 1.54 1.47 1.54
Other Financing Activities, net		 0.14 -2.22 0.17 -2.32 -0.65 -1.30 -1.98 -1.43 -0.74 0.00 0.00
Effect of Exchange Rate Changes		 -0.66 0.32 -0.35 -0.32 -0.10 - - - -0.30 0.14 -0.27
Cash Interest Paid		 2.13 2.23 2.31 2.66 2.39 2.28 2.07 1.66 1.50 1.11 0.50
Cash Income Taxes Paid		 2.38 3.41 2.56 2.51 1.78 2.06 1.77 3.21 3.31 4.21 7.69

Quarterly Cash Flow Statements for Franklin Covey

This table details how cash moves in and out of Franklin Covey's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q3 2026
Period end date 5/31/2023 8/31/2023 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2025 2/28/2025 5/31/2025 8/31/2025 5/31/2026
Net Change in Cash & Equivalents		 -16 -1.10 -4.27 6.95 -4.33 12 -14 -13 -6.69 -2.01 -1.75
Net Cash From Operating Activities		 15 9.79 17 13 8.17 22 0.10 -1.37 6.26 9.94 1.13
Net Cash From Continuing Operating Activities		 15 9.79 17 13 8.17 22 0.10 -1.37 6.26 9.94 1.13
Net Income / (Loss) Continuing Operations		 4.56 6.81 4.85 0.87 5.72 12 -3.29 -1.08 -1.41 4.37 3.09
Consolidated Net Income / (Loss)		 4.56 6.81 4.85 0.87 5.72 12 -3.29 -1.08 -1.41 4.37 3.09
Depreciation Expense		 2.02 2.21 2.16 1.98 2.05 1.96 1.79 2.12 2.11 2.19 1.80
Amortization Expense		 0.96 0.90 0.89 1.01 1.03 1.00 1.44 1.26 1.20 1.39 1.75
Non-Cash Adjustments To Reconcile Net Income		 3.31 3.16 2.90 2.30 2.83 3.05 1.43 1.35 2.22 0.08 1.50
Changes in Operating Assets and Liabilities, net		 3.89 -3.30 6.64 6.61 -3.46 3.92 -1.26 -5.02 2.14 1.92 -7.01
Net Cash From Investing Activities		 -2.47 -3.16 -3.74 -1.75 -2.33 -3.50 -3.75 -2.22 -3.49 -8.42 -2.15
Net Cash From Continuing Investing Activities		 -2.47 -3.16 -3.74 -1.75 -2.33 -3.50 -3.75 -2.22 -3.49 -8.42 -2.15
Purchase of Property, Plant & Equipment		 -0.90 -0.97 -1.07 -0.64 -0.90 -1.08 -1.73 -1.27 -1.78 -4.20 -1.16
Other Investing Activities, net		 -1.56 -2.19 -2.67 -1.10 -1.43 -1.67 -2.02 -0.95 -1.72 -3.47 -0.99
Net Cash From Financing Activities		 -28 -7.59 -18 -3.90 -10 -6.69 -10 -9.31 -9.72 -3.17 -0.52
Net Cash From Continuing Financing Activities		 -28 -7.59 -18 -3.90 -10 -6.69 -10 -9.31 -9.72 -3.17 -0.52
Repayment of Debt		 -11 -2.08 -2.11 -2.12 -2.98 -2.17 0.00 -0.96 -1.82 -0.22 -0.84
Repurchase of Common Equity		 -25 -5.88 -16 -2.11 -7.43 -4.91 -11 -8.70 -8.33 -3.38 -0.01
Issuance of Common Equity		 0.42 0.38 0.36 0.33 0.39 0.39 0.29 0.36 0.43 0.44 0.32
Effect of Exchange Rate Changes		 - -0.14 0.09 -0.18 -0.16 0.40 -0.14 0.00 0.27 -0.36 -0.20
Cash Interest Paid		 0.42 0.34 0.34 0.28 0.32 0.18 0.07 0.12 0.16 0.07 0.06
Cash Income Taxes Paid		 0.85 0.86 0.82 0.82 1.32 1.24 0.35 5.28 1.02 0.64 0.15

Annual Balance Sheets for Franklin Covey

This table presents Franklin Covey's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 8/31/2015 8/31/2016 8/31/2017 8/31/2018 8/31/2019 8/31/2020 8/31/2021 8/31/2022 8/31/2023 8/31/2024 8/31/2025
Total Assets		 201 191 211 214 225 205 250 259 246 262 243
Total Current Assets		 95 90 92 100 119 102 137 156 145 160 129
Cash & Equivalents		 16 10 8.92 10 28 27 47 61 38 49 32
Accounts Receivable		 68 68 66 72 73 56 71 73 82 86 68
Inventories, net		 3.95 5.04 3.35 3.16 3.48 2.97 2.50 3.53 4.21 4.00 5.17
Prepaid Expenses		 2.57 2.95 3.57 3.86 3.91 3.65 3.25 4.71 4.40 5.11 24
Plant, Property, & Equipment, net		 15 16 20 21 19 16 12 9.80 10 8.74 14
Total Noncurrent Assets		 90 85 99 92 87 88 101 93 91 93 99
Goodwill		 20 20 24 24 24 24 31 31 31 31 31
Intangible Assets		 53 50 57 52 48 47 50 45 41 38 35
Noncurrent Deferred & Refundable Income Taxes		 - - 1.65 3.22 5.05 1.09 4.95 4.69 1.66 0.87 0.23
Other Noncurrent Operating Assets		 15 14 16 13 10 16 15 13 17 23 33
Total Liabilities & Shareholders' Equity		 201 191 211 214 225 205 250 259 246 262 243
Total Liabilities		 75 97 126 133 143 146 170 176 167 178 176
Total Current Liabilities		 40 54 81 95 104 103 137 154 152 162 157
Short-Term Debt		 1.47 5.41 8.12 12 7.34 5.00 5.84 5.84 5.84 0.84 0.82
Accounts Payable		 8.31 10 9.12 9.79 9.67 5.62 6.95 11 6.50 7.86 8.78
Accrued Expenses		 17 17 23 21 24 23 35 34 28 32 25
Customer Deposits		 - - - - - - - - 12 17 16
Current Deferred Revenue		 13 21 41 52 56 59 75 86 95 101 107
Other Current Liabilities		 - - - - 5.97 9.99 14 17 3.54 3.11 0.00
Total Noncurrent Liabilities		 36 43 45 39 39 43 33 23 16 16 19
Long-Term Debt		 25 33 38 33 32 15 13 7.27 1.54 0.78 0.00
Noncurrent Deferred & Payable Income Tax Liabilities		 7.10 6.67 1.03 0.21 0.18 5.30 0.38 0.20 2.04 3.13 3.99
Other Noncurrent Operating Liabilities		 3.80 3.17 5.74 5.50 7.53 23 20 15 12 12 15
Total Equity & Noncontrolling Interests		 126 94 85 81 82 59 80 83 79 83 67
Total Preferred & Common Equity		 126 94 85 81 82 59 80 83 79 83 67
Total Common Equity		 126 94 85 81 82 59 80 83 79 83 67
Common Stock		 210 213 214 213 217 213 216 222 234 233 232
Retained Earnings		 70 77 69 64 59 50 64 82 100 123 126
Treasury Stock		 -154 -197 -199 -196 -195 -204 -201 -220 -254 -272 -290
Accumulated Other Comprehensive Income / (Loss)		 0.19 1.22 0.67 0.34 0.27 0.64 0.71 -0.54 -0.99 -0.77 -1.03

Quarterly Balance Sheets for Franklin Covey

This table presents Franklin Covey's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q2 2026 Q3 2026
Period end date 11/30/2022 2/28/2023 5/31/2023 11/30/2023 2/29/2024 5/31/2024 11/30/2025 2/28/2025 5/31/2025 2/28/2026 5/31/2026
Total Assets		 237 234 218 219 222 221 221 221 218 206 198
Total Current Assets		 136 131 117 117 122 120 109 121 111 95 92
Cash & Equivalents		 58 55 39 34 41 37 18 40 34 14 12
Accounts Receivable		 57 54 55 60 57 60 59 53 50 50 50
Inventories, net		 3.48 3.47 4.57 4.12 4.20 4.64 5.30 4.09 4.06 5.34 5.80
Prepaid Expenses		 17 19 17 19 20 18 27 23 23 26 24
Plant, Property, & Equipment, net		 9.47 9.85 9.70 9.52 8.71 8.63 14 9.55 9.87 13 13
Total Noncurrent Assets		 92 93 91 92 91 92 99 91 97 98 94
Goodwill		 31 31 31 31 31 31 31 31 31 31 31
Intangible Assets		 44 43 42 39 38 39 34 36 36 32 32
Noncurrent Deferred & Refundable Income Taxes		 4.28 3.56 2.27 1.68 1.66 1.64 0.23 0.82 0.85 0.24 0.24
Other Noncurrent Operating Assets		 12 16 16 20 20 21 33 23 30 34 30
Total Liabilities & Shareholders' Equity		 237 234 218 219 222 221 221 221 218 206 198
Total Liabilities		 148 143 143 148 151 149 167 149 153 168 155
Total Current Liabilities		 128 125 128 135 138 137 149 134 132 152 140
Short-Term Debt		 5.84 5.84 5.84 4.59 3.34 2.09 0.83 0.84 0.82 0.84 0.00
Accounts Payable		 6.88 8.49 7.10 5.67 7.73 6.19 5.53 6.80 6.23 6.61 6.42
Accrued Expenses		 23 19 24 21 19 22 21 17 21 22 21
Customer Deposits		 - - - - - 22 25 20 20 25 20
Current Deferred Revenue		 74 74 70 83 82 80 96 88 83 98 93
Other Current Liabilities		 17 18 21 20 26 3.81 0.00 1.20 0.22 0.00 0.00
Total Noncurrent Liabilities		 20 18 15 14 13 12 19 15 20 16 15
Long-Term Debt		 6.05 4.82 2.76 1.56 1.58 0.76 0.00 0.80 0.00 0.00 0.00
Noncurrent Deferred & Payable Income Tax Liabilities		 0.20 0.20 0.20 1.01 1.06 1.85 5.10 2.98 3.15 4.50 4.02
Other Noncurrent Operating Liabilities		 14 13 12 11 10 9.61 13 11 17 12 11
Total Equity & Noncontrolling Interests		 90 91 75 71 71 72 54 73 66 38 43
Total Preferred & Common Equity		 90 91 75 71 71 72 54 73 66 38 43
Total Common Equity		 90 91 75 71 71 72 54 73 66 38 43
Common Stock		 224 227 230 226 227 230 231 229 232 231 231
Retained Earnings		 87 88 93 105 106 111 123 123 122 121 124
Treasury Stock		 -220 -224 -248 -259 -261 -268 -298 -279 -287 -313 -311
Accumulated Other Comprehensive Income / (Loss)		 -0.67 -0.53 -0.67 -0.94 -1.08 -1.25 -1.24 -1.01 -0.86 -1.16 -1.17

Annual Metrics And Ratios for Franklin Covey

This table displays calculated financial ratios and metrics derived from Franklin Covey's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 8/31/2015 8/31/2016 8/31/2017 8/31/2018 8/31/2019 8/31/2020 8/31/2021 8/31/2022 8/31/2023 8/31/2024 8/31/2025
DEI Shares Outstanding		 16,564,200.00 14,176,603.00 13,859,482.00 13,907,731.00 13,974,222.00 13,877,984.00 14,156,827.00 - - - 12,641,822.00
DEI Adjusted Shares Outstanding		 16,564,200.00 14,176,603.00 13,859,482.00 13,907,731.00 13,974,222.00 13,877,984.00 14,156,827.00 - - - 12,641,822.00
DEI Earnings Per Adjusted Shares Outstanding		 0.67 19.56 -0.52 -0.42 -0.07 -0.68 0.97 - - - 0.22
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 2.33% 90.58% -53.70% 13.23% 7.44% -11.94% 12.96% 17.25% 6.73% 2.39% -7.02%
EBITDA Growth		 -7.67% -20.13% -90.09% 421.79% 49.54% -3.21% 27.61% 60.50% 2.05% 16.03% -57.43%
EBIT Growth		 -18.68% -26.65% -162.05% 66.21% 198.81% 4.98% 164.91% 192.24% 11.35% 25.34% -82.74%
NOPAT Growth		 -39.37% -34.57% -176.20% 62.09% -94.72% -690.04% 150.12% 8.85% -8.37% 29.14% -87.67%
Net Income Growth		 -38.47% -36.88% -202.22% 17.92% 82.62% -822.29% 244.39% 35.29% -3.52% 31.61% -86.89%
EPS Growth		 -38.32% -28.79% -210.64% 17.31% 83.72% -871.43% 241.18% 32.29% -2.36% 40.32% -86.21%
Operating Cash Flow Growth		 44.50% 24.72% -46.86% -2.86% 80.61% -9.49% 67.53% 13.16% -31.61% 68.61% -51.91%
Free Cash Flow Firm Growth		 6,699.14% 4.13% -131.57% 167.46% 284.83% -73.22% 306.00% 85.32% -83.93% 513.28% -91.65%
Invested Capital Growth		 -5.75% -9.92% 0.49% -5.67% -19.27% -43.93% -2.03% -30.93% 35.01% -24.51% -0.13%
Revenue Q/Q Growth		 -0.32% 97.42% -52.57% 2.59% 0.15% -7.53% 9.77% 3.90% -0.30% 2.20% -4.60%
EBITDA Q/Q Growth		 0.27% 0.15% -67.84% 10.69% 5.32% -20.00% 1.67% 11.83% 3.85% 18.98% -32.90%
EBIT Q/Q Growth		 -1.16% 3.47% -217.70% 15.58% 90.77% -61.99% 7.60% 22.52% 7.79% 28.65% -63.77%
NOPAT Q/Q Growth		 -32.59% 0.94% -223.38% 3.61% -529.22% -471.95% 2.54% 23.21% 6.13% 27.25% -72.31%
Net Income Q/Q Growth		 -30.09% 0.80% -74.67% -95.84% 80.02% -107.82% 6.46% 25.72% 7.46% 28.17% -71.20%
EPS Q/Q Growth		 -29.79% 14.63% -52.94% -104.76% 81.08% -106.06% 5.49% 23.30% 10.71% 30.83% -69.62%
Operating Cash Flow Q/Q Growth		 8.03% 0.07% -22.71% 18.00% 13.23% -9.74% 16.30% -4.75% -7.57% 25.08% -29.17%
Free Cash Flow Firm Q/Q Growth		 6.60% -1.01% -227.90% 180.91% -27.25% -69.11% 7.96% -31.71% -45.46% 47.95% -81.87%
Invested Capital Q/Q Growth		 -0.52% -0.34% 6.46% -2.33% -1.88% -28.74% -30.10% -4.85% 9.18% -6.12% 10.24%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 65.78% 67.56% 66.21% 70.70% 70.69% 73.25% 77.13% 76.82% 76.10% 76.97% 76.22%
EBITDA Margin		 14.83% 6.22% 1.33% 6.13% 8.53% 9.38% 10.59% 14.50% 13.86% 15.71% 7.19%
Operating Margin		 9.30% 3.46% -4.79% -1.60% 1.18% 1.54% 3.61% 9.01% 9.40% 11.50% 2.14%
EBIT Margin		 9.13% 3.51% -4.71% -1.41% 1.29% 1.54% 3.61% 9.01% 9.40% 11.50% 2.14%
Profit (Net Income) Margin		 5.29% 1.75% -3.87% -2.81% -0.45% -4.75% 6.08% 7.01% 6.34% 8.15% 1.15%
Tax Burden Percent		 63.84% 58.90% 65.74% 106.65% -172.80% -1,185.30% 224.25% 83.53% 68.73% 70.82% 50.57%
Interest Burden Percent		 90.85% 84.72% 125.05% 187.25% 20.32% 26.03% 74.99% 93.20% 98.13% 100.01% 106.36%
Effective Tax Rate		 36.16% 41.10% 0.00% 0.00% 272.80% 1,285.30% -124.25% 16.47% 31.27% 29.18% 49.43%
Return on Invested Capital (ROIC)		 8.94% 6.34% -5.09% -1.98% -4.39% -49.78% 35.08% 45.64% 43.56% 55.79% 8.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -1.17% 0.34% -8.00% -11.72% 10.99% 1,243.27% 60.50% 49.18% 44.42% 55.79% 7.53%
Return on Net Nonoperating Assets (RNNOA)		 -0.12% 0.06% -2.94% -5.13% 3.13% 36.45% -15.52% -22.98% -21.53% -26.87% -3.91%
Return on Equity (ROE)		 8.81% 6.40% -8.02% -7.11% -1.26% -13.34% 19.56% 22.66% 22.02% 28.93% 4.09%
Cash Return on Invested Capital (CROIC)		 14.86% 16.78% -5.57% 3.86% 16.94% 6.50% 37.13% 82.24% 13.76% 83.72% 8.13%
Operating Return on Assets (OROA)		 9.45% 7.18% -4.34% -1.39% 1.33% 1.42% 3.56% 9.31% 10.44% 13.02% 2.26%
Return on Assets (ROA)		 5.48% 3.58% -3.57% -2.77% -0.47% -4.38% 5.99% 7.24% 7.04% 9.22% 1.22%
Return on Common Equity (ROCE)		 8.81% 6.40% -8.02% -7.11% -1.26% -13.34% 19.56% 22.66% 22.02% 28.93% 4.09%
Return on Equity Simple (ROE_SIMPLE)		 8.86% 7.49% -8.43% -7.31% -1.25% -15.87% 17.06% 22.25% 22.61% 28.15% 0.00%
Net Operating Profit after Tax (NOPAT)		 12 8.16 -6.22 -2.36 -4.59 -36 18 20 18 23 2.88
NOPAT Margin		 5.94% 2.04% -3.36% -1.12% -2.04% -18.26% 8.10% 7.52% 6.46% 8.15% 1.08%
Net Nonoperating Expense Percent (NNEP)		 10.11% 6.00% 2.91% 9.74% -15.38% -1,293.06% -25.42% -3.54% -0.86% 0.01% 0.47%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - - 4.26%
Cost of Revenue to Revenue		 34.22% 32.44% 33.79% 29.30% 29.31% 26.75% 22.87% 23.18% 23.90% 23.03% 23.78%
SG&A Expenses to Revenue		 51.83% 28.39% 65.39% 65.92% 62.36% 65.50% 68.52% 63.94% 63.44% 61.25% 68.40%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 56.47% -3.46% 71.01% 72.30% 69.52% 71.71% 73.52% 67.81% 66.71% 65.46% 74.09%
Earnings before Interest and Taxes (EBIT)		 19 14 -8.72 -2.95 2.91 3.06 8.10 24 26 33 5.70
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 31 25 2.46 13 19 19 24 38 39 45 19
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.21 2.46 3.06 4.42 6.27 4.61 7.71 7.96 7.16 6.34 3.70
Price to Tangible Book Value (P/TBV)		 5.31 9.75 73.38 81.92 50.88 0.00 0.00 97.51 81.39 37.26 216.91
Price to Revenue (P/Rev)		 1.32 0.58 1.41 1.70 2.28 1.38 2.75 2.51 2.01 1.84 0.93
Price to Earnings (P/E)		 24.93 0.83 0.00 0.00 0.00 0.00 44.95 38.37 32.50 22.32 88.19
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 4.01% 120.46% 0.00% 0.00% 0.00% 0.00% 2.22% 2.61% 3.08% 4.48% 1.13%
Enterprise Value to Invested Capital (EV/IC)		 2.12 2.12 2.43 3.38 5.63 5.10 11.45 17.28 11.14 13.31 6.01
Enterprise Value to Revenue (EV/Rev)		 1.37 0.65 1.61 1.86 2.33 1.34 2.62 2.33 1.90 1.67 0.81
Enterprise Value to EBITDA (EV/EBITDA)		 9.22 10.39 120.95 30.42 27.33 14.34 24.71 16.05 13.69 10.64 11.26
Enterprise Value to EBIT (EV/EBIT)		 14.97 18.38 0.00 0.00 180.36 87.25 72.43 25.84 20.20 14.53 37.94
Enterprise Value to NOPAT (EV/NOPAT)		 23.02 31.68 0.00 0.00 0.00 0.00 32.30 30.94 29.39 20.52 75.02
Enterprise Value to Operating Cash Flow (EV/OCF)		 10.96 7.91 17.17 23.20 17.25 9.68 12.71 11.71 14.90 7.97 7.47
Enterprise Value to Free Cash Flow (EV/FCFF)		 13.85 11.98 0.00 85.10 29.71 56.34 30.52 17.17 93.02 13.67 73.85
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.21 0.41 0.55 0.56 0.48 0.34 0.24 0.16 0.09 0.02 0.01
Long-Term Debt to Equity		 0.20 0.35 0.45 0.41 0.39 0.25 0.16 0.09 0.02 0.01 0.00
Financial Leverage		 0.11 0.17 0.37 0.44 0.29 0.03 -0.26 -0.47 -0.48 -0.48 -0.52
Leverage Ratio		 1.61 1.79 2.25 2.56 2.70 3.04 3.27 3.13 3.13 3.14 3.36
Compound Leverage Factor		 1.46 1.51 2.81 4.80 0.55 0.79 2.45 2.92 3.07 3.14 3.58
Debt to Total Capital		 17.20% 29.21% 35.29% 35.97% 32.22% 25.17% 19.06% 13.66% 8.57% 1.90% 1.22%
Short-Term Debt to Total Capital		 0.97% 4.09% 6.18% 9.87% 6.06% 6.29% 5.91% 6.08% 6.78% 0.99% 1.22%
Long-Term Debt to Total Capital		 16.23% 25.12% 29.11% 26.10% 26.16% 18.88% 13.15% 7.58% 1.78% 0.91% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 82.80% 70.79% 64.71% 64.03% 67.78% 74.83% 80.94% 86.34% 91.43% 98.10% 98.79%
Debt to EBITDA		 0.84 1.56 18.82 3.52 2.03 1.07 0.79 0.34 0.19 0.04 0.04
Net Debt to EBITDA		 0.32 1.13 15.20 2.73 0.59 -0.38 -1.20 -1.24 -0.79 -1.04 -1.61
Long-Term Debt to EBITDA		 0.79 1.34 15.53 2.55 1.65 0.81 0.55 0.19 0.04 0.02 0.00
Debt to NOPAT		 2.09 4.74 -7.46 -19.19 -8.50 -0.55 1.04 0.66 0.41 0.07 0.29
Net Debt to NOPAT		 0.79 3.46 -6.03 -14.89 -2.46 0.20 -1.57 -2.40 -1.70 -2.01 -10.70
Long-Term Debt to NOPAT		 1.97 4.08 -6.16 -13.93 -6.90 -0.41 0.71 0.37 0.08 0.03 0.00
Altman Z-Score		 4.39 4.55 2.51 2.98 3.66 2.48 3.54 4.01 4.05 3.94 2.61
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.41 1.66 1.14 1.06 1.15 0.99 1.00 1.01 0.96 0.99 0.82
Quick Ratio		 2.12 1.45 0.93 0.87 0.97 0.81 0.86 0.87 0.79 0.83 0.64
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 21 22 -6.81 4.60 18 4.74 19 36 5.73 35 2.93
Operating Cash Flow to CapEx		 1,070.73% 818.06% 241.51% 258.29% 733.25% 658.93% 2,882.46% 1,644.76% 791.54% 1,631.21% 351.11%
Free Cash Flow to Firm to Interest Expense		 9.70 9.54 -2.83 1.72 7.50 2.04 9.16 21.27 3.62 31.38 5.19
Operating Cash Flow to Interest Expense		 12.26 14.43 7.21 6.30 12.91 11.89 22.00 31.20 22.58 53.85 51.29
Operating Cash Flow Less CapEx to Interest Expense		 11.11 12.67 4.22 3.86 11.15 10.09 21.24 29.30 19.72 50.55 36.68
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.03 2.04 0.92 0.99 1.03 0.92 0.99 1.03 1.11 1.13 1.06
Accounts Receivable Turnover		 3.21 5.91 2.76 3.03 3.11 3.06 3.53 3.67 3.63 3.42 3.46
Inventory Turnover		 13.93 28.87 14.91 18.88 19.89 16.45 18.74 20.23 17.32 16.11 13.85
Fixed Asset Turnover		 12.81 25.34 10.35 10.20 11.27 11.57 16.45 24.65 28.28 30.60 23.16
Accounts Payable Turnover		 7.08 13.90 6.42 6.50 6.79 6.94 8.16 6.84 7.72 9.21 7.63
Days Sales Outstanding (DSO)		 113.83 61.80 132.24 120.29 117.54 119.21 103.46 99.46 100.51 106.70 105.52
Days Inventory Outstanding (DIO)		 26.20 12.64 24.48 19.34 18.35 22.19 19.47 18.04 21.07 22.66 26.35
Days Payable Outstanding (DPO)		 51.58 26.27 56.84 56.14 53.77 52.56 44.75 53.35 47.28 39.62 47.83
Cash Conversion Cycle (CCC)		 88.46 48.18 99.87 83.49 82.12 88.84 78.19 64.15 74.31 89.74 84.04
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 135 122 123 116 93 52 51 35 48 36 36
Invested Capital Turnover		 1.51 3.11 1.52 1.76 2.16 2.73 4.33 6.07 6.74 6.85 7.41
Increase / (Decrease) in Invested Capital		 -8.26 -13 0.60 -6.95 -22 -41 -1.06 -16 12 -12 -0.05
Enterprise Value (EV)		 287 258 298 391 525 267 587 612 533 480 216
Market Capitalization		 277 230 261 356 514 274 615 659 563 527 247
Book Value per Share		 $7.58 $6.61 $6.14 $5.79 $5.87 $4.28 $5.64 $5.98 $5.96 $6.35 $5.29
Tangible Book Value per Share		 $3.15 $1.67 $0.26 $0.31 $0.72 ($0.86) ($0.10) $0.49 $0.52 $1.08 $0.09
Total Capital		 152 132 131 126 121 79 99 96 86 85 68
Total Debt		 26 39 46 45 39 20 19 13 7.37 1.61 0.82
Total Long-Term Debt		 25 33 38 33 32 15 13 7.27 1.54 0.78 0.00
Net Debt		 9.84 28 37 35 11 -7.14 -29 -47 -31 -47 -31
Capital Expenditures (CapEx)		 2.45 3.99 7.19 6.53 4.15 4.18 1.60 3.18 4.52 3.69 8.25
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 41 31 10 7.57 -4.57 -23 -41 -53 -39 -50 -59
Debt-free Net Working Capital (DFNWC)		 57 41 19 18 23 4.14 6.00 7.92 -0.80 -1.37 -27
Net Working Capital (NWC)		 56 36 11 5.32 16 -0.86 0.17 2.09 -6.63 -2.20 -28
Net Nonoperating Expense (NNE)		 1.35 1.14 0.96 3.53 -3.56 -27 4.54 1.34 0.34 -0.00 -0.18
Net Nonoperating Obligations (NNO)		 9.84 28 37 35 11 -7.14 -29 -47 -31 -47 -31
Total Depreciation and Amortization (D&A)		 12 11 11 16 16 16 16 14 13 12 14
Debt-free, Cash-free Net Working Capital to Revenue		 19.54% 7.66% 5.62% 3.61% -2.03% -11.59% -18.47% -20.01% -13.91% -17.42% -21.98%
Debt-free Net Working Capital to Revenue		 27.28% 10.27% 10.43% 8.45% 10.26% 2.08% 2.68% 3.01% -0.28% -0.48% -10.11%
Net Working Capital to Revenue		 26.57% 8.92% 6.05% 2.54% 7.01% -0.44% 0.08% 0.79% -2.36% -0.77% -10.42%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.66 $0.47 ($0.52) ($0.43) ($0.07) ($0.68) $0.97 $1.30 $1.30 $1.78 $0.24
Adjusted Weighted Average Basic Shares Outstanding		 16.74M 14.94M 13.82M 13.85M 13.98M 14.03M 14.09M 14.15M 13.64M 13.17M 12.93M
Adjusted Diluted Earnings per Share		 $0.66 $0.47 ($0.52) ($0.43) ($0.07) ($0.68) $0.96 $1.27 $1.24 $1.74 $0.24
Adjusted Weighted Average Diluted Shares Outstanding		 16.92M 15.08M 13.82M 13.85M 13.98M 14.03M 14.14M 14.56M 14.30M 13.47M 13.05M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($0.52) ($0.43) ($0.07) ($0.68) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 16.22M 13.79M 13.70M 13.92M 13.95M 13.89M 14.29M 13.90M 13.43M 13.18M 12.16M
Normalized Net Operating Profit after Tax (NOPAT)		 14 8.61 -4.13 -2.36 1.86 3.29 5.67 20 19 26 6.28
Normalized NOPAT Margin		 6.51% 2.15% -2.23% -1.12% 0.82% 1.66% 2.53% 7.52% 6.60% 9.12% 2.35%
Pre Tax Income Margin		 8.29% 2.98% -5.89% -2.63% 0.26% 0.40% 2.71% 8.39% 9.22% 11.50% 2.27%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 8.97 6.21 -3.62 -1.10 1.24 1.32 3.86 14.13 16.65 29.53 10.10
NOPAT to Interest Expense		 5.83 3.60 -2.58 -0.88 -1.95 -15.64 8.65 11.81 11.45 20.91 5.11
EBIT Less CapEx to Interest Expense		 7.82 4.45 -6.61 -3.54 -0.53 -0.49 3.10 12.24 13.80 26.23 -4.51
NOPAT Less CapEx to Interest Expense		 4.69 1.84 -5.57 -3.32 -3.71 -17.44 7.89 9.91 8.59 17.61 -9.50
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 129.79% 621.24% -75.73% -34.08% -1.17% -148.08% 21.81% 129.41% 199.96% 131.39% 859.65%

Quarterly Metrics And Ratios for Franklin Covey

This table displays calculated financial ratios and metrics derived from Franklin Covey's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q2 2026 Q3 2026
Period end date 8/31/2023 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 2/28/2026 5/31/2026
DEI Shares Outstanding		 - - - - - - - 12,987,725.00 12,641,822.00 11,552,552.00 11,272,444.00
DEI Adjusted Shares Outstanding		 - - - - - - - 12,987,725.00 12,641,822.00 11,552,552.00 11,272,444.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - -0.10 0.33 -0.17 0.27
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -1.08% -1.40% -0.68% 2.70% 7.91% 1.00% -2.81% -8.52% -15.31% 0.06% 1.02%
EBITDA Growth		 11.79% -14.27% -24.54% 19.64% 52.61% -43.71% -56.69% -90.29% -45.11% -109.72% 598.02%
EBIT Growth		 22.00% -16.63% -49.01% 26.95% 69.63% -72.32% -200.90% -126.41% -56.01% -37.39% 290.47%
NOPAT Growth		 18.09% -0.42% -49.63% 25.22% 72.85% -77.60% -214.35% -127.02% -63.62% -37.39% 301.49%
Net Income Growth		 22.12% 3.94% -49.74% 25.38% 75.51% -75.65% -223.11% -124.63% -63.43% -84.20% 318.95%
EPS Growth		 33.33% 12.50% -50.00% 34.38% 85.42% -75.00% -233.33% -125.58% -61.80% -112.50% 345.45%
Operating Cash Flow Growth		 -23.01% 477.99% 55.95% -44.55% 123.39% -18.88% -110.72% -23.37% -54.56% 0.00% -82.04%
Free Cash Flow Firm Growth		 -125.36% -44.12% 451.47% 647.90% 529.48% 166.12% -99.66% -61.94% -81.46% 16,090.34% 14.89%
Invested Capital Growth		 35.01% -1.53% -25.72% -12.20% -24.51% -32.11% -3.05% -14.95% -0.13% -25.48% -5.27%
Revenue Q/Q Growth		 9.12% -12.26% -10.33% 19.62% 14.65% -17.88% -13.71% 12.60% 6.15% 0.00% 13.68%
EBITDA Q/Q Growth		 43.24% -38.74% -47.02% 157.36% 82.72% -77.40% -59.24% -42.28% 932.52% 0.00% 4,199.47%
EBIT Q/Q Growth		 60.82% -49.58% -72.94% 478.57% 114.89% -91.77% -198.64% -51.41% 458.01% 0.00% 309.91%
NOPAT Q/Q Growth		 51.24% -28.92% -81.82% 540.71% 108.78% -90.79% -192.79% -51.41% 381.09% 0.00% 322.06%
Net Income Q/Q Growth		 49.29% -28.79% -81.98% 554.58% 108.98% -90.12% -191.11% -30.95% 410.29% 0.00% 255.65%
EPS Q/Q Growth		 50.00% -25.00% -83.33% 616.67% 106.98% -89.89% -188.89% -37.50% 409.09% 0.00% 258.82%
Operating Cash Flow Q/Q Growth		 -33.57% 78.10% -26.75% -36.02% 167.61% -35.33% -109.68% 557.49% 58.68% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 -172.80% 201.12% 132.87% -14.71% 113.84% -37.34% -99.70% 9,349.21% 4.18% 0.00% -32.94%
Invested Capital Q/Q Growth		 9.18% -10.69% -18.39% 10.33% -6.12% -19.69% 16.55% -3.21% 10.24% 0.00% 23.03%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 76.08% 76.43% 76.38% 76.60% 78.14% 76.30% 76.74% 76.46% 75.50% 75.90% 73.88%
EBITDA Margin		 17.55% 12.25% 7.24% 15.57% 24.82% 6.83% 3.23% 1.65% 16.09% -0.32% 11.43%
Operating Margin		 13.56% 7.79% 2.35% 11.37% 21.31% 2.14% -2.44% -3.28% 11.07% -3.35% 6.19%
EBIT Margin		 13.56% 7.79% 2.35% 11.37% 21.31% 2.14% -2.44% -3.28% 11.07% -3.35% 6.19%
Profit (Net Income) Margin		 8.74% 7.09% 1.42% 7.80% 14.21% 1.71% -1.81% -2.10% 6.14% -3.32% 4.55%
Tax Burden Percent		 65.22% 91.94% 61.77% 68.40% 66.46% 74.42% 79.82% 66.24% 54.96% 96.12% 74.05%
Interest Burden Percent		 98.83% 99.01% 98.13% 100.25% 100.35% 107.59% 92.65% 96.55% 100.86% 103.15% 99.29%
Effective Tax Rate		 34.78% 8.06% 38.23% 31.60% 33.54% 25.58% 0.00% 0.00% 45.04% 0.00% 25.95%
Return on Invested Capital (ROIC)		 59.63% 46.56% 9.92% 53.18% 97.00% 12.77% -14.25% -18.09% 45.06% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 59.84% 46.69% 9.96% 53.13% 96.89% 12.56% -14.10% -18.49% 44.96% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -29.01% -21.60% -4.94% -23.35% -46.66% -6.60% 7.35% 8.94% -23.35% 0.00% 0.00%
Return on Equity (ROE)		 30.62% 24.95% 4.98% 29.83% 50.34% 6.16% -6.90% -9.15% 21.71% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 13.76% 43.67% 71.71% 57.73% 83.72% 93.01% 54.35% 45.45% 8.13% 0.00% 0.00%
Operating Return on Assets (OROA)		 15.06% 9.55% 2.88% 14.57% 24.13% 2.68% -3.15% -4.18% 11.72% 0.00% 0.00%
Return on Assets (ROA)		 9.71% 8.69% 1.74% 9.99% 16.09% 2.15% -2.33% -2.68% 6.50% 0.00% 0.00%
Return on Common Equity (ROCE)		 30.62% 24.95% 4.98% 29.83% 50.34% 6.16% -6.90% -9.15% 21.71% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 25.48% 24.14% 25.30% 0.00% 24.47% 24.52% 16.24% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 6.89 4.90 0.89 5.71 12 1.10 -1.02 -1.54 4.33 -1.40 3.11
NOPAT Margin		 8.84% 7.16% 1.45% 7.78% 14.16% 1.59% -1.71% -2.30% 6.08% -2.35% 4.58%
Net Nonoperating Expense Percent (NNEP)		 -0.21% -0.13% -0.04% 0.04% 0.11% 0.21% -0.15% 0.40% 0.10% -2.26% -0.10%
Return On Investment Capital (ROIC_SIMPLE)		 - 6.39% - - - 1.33% -1.37% -2.32% 6.40% -3.60% 7.24%
Cost of Revenue to Revenue		 23.92% 23.57% 23.62% 23.40% 21.86% 23.70% 23.26% 23.54% 24.50% 24.10% 26.12%
SG&A Expenses to Revenue		 58.96% 64.63% 66.47% 61.48% 53.82% 68.33% 75.63% 69.54% 61.36% 72.92% 63.80%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 62.52% 68.64% 74.03% 65.23% 56.83% 74.16% 79.18% 79.74% 64.43% 79.25% 67.69%
Earnings before Interest and Taxes (EBIT)		 11 5.33 1.44 8.34 18 1.48 -1.46 -2.20 7.89 -2.00 4.20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 14 8.38 4.44 11 21 4.72 1.92 1.11 11 -0.19 7.75
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 7.16 7.41 7.16 6.80 6.34 5.95 5.82 4.63 3.70 3.95 6.23
Price to Tangible Book Value (P/TBV)		 81.39 0.00 410.41 229.90 37.26 39.11 80.55 0.00 216.91 0.00 0.00
Price to Revenue (P/Rev)		 2.01 1.87 1.82 1.75 1.84 1.67 1.47 1.08 0.93 0.00 0.00
Price to Earnings (P/E)		 32.50 29.51 30.65 27.77 22.32 24.35 23.65 27.51 88.19 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 3.08% 3.39% 3.26% 3.60% 4.48% 4.11% 4.23% 3.64% 1.13% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 11.14 11.58 13.53 11.89 13.31 14.77 11.35 8.28 6.01 5.46 8.25
Enterprise Value to Revenue (EV/Rev)		 1.90 1.77 1.69 1.63 1.67 1.49 1.34 0.97 0.81 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 13.69 13.19 13.07 12.05 10.64 10.32 9.84 9.46 11.26 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 20.20 19.55 19.71 17.80 14.53 14.66 14.58 17.20 37.94 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 29.39 27.29 27.33 24.86 20.52 21.81 21.80 26.00 75.02 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 14.90 9.86 8.61 9.49 7.97 7.51 8.95 6.62 7.47 4.23 9.32
Enterprise Value to Free Cash Flow (EV/FCFF)		 93.02 26.33 16.08 19.26 13.67 12.84 20.56 16.75 73.85 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.09 0.09 0.07 0.04 0.02 0.02 0.02 0.01 0.01 0.02 0.00
Long-Term Debt to Equity		 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Financial Leverage		 -0.48 -0.46 -0.50 -0.44 -0.48 -0.53 -0.52 -0.48 -0.52 -0.47 -0.41
Leverage Ratio		 3.13 2.85 2.81 2.99 3.14 3.04 3.09 3.19 3.36 3.87 3.84
Compound Leverage Factor		 3.09 2.82 2.76 3.00 3.15 3.27 2.86 3.08 3.39 3.99 3.81
Debt to Total Capital		 8.57% 8.01% 6.49% 3.79% 1.90% 1.97% 2.21% 1.23% 1.22% 2.15% 0.00%
Short-Term Debt to Total Capital		 6.78% 5.98% 4.40% 2.78% 0.99% 1.01% 1.13% 1.23% 1.22% 2.15% 0.00%
Long-Term Debt to Total Capital		 1.78% 2.03% 2.08% 1.01% 0.91% 0.96% 1.08% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 91.43% 91.99% 93.51% 96.21% 98.10% 98.03% 97.79% 98.77% 98.79% 97.85% 100.00%
Debt to EBITDA		 0.19 0.16 0.14 0.08 0.04 0.04 0.04 0.03 0.04 0.00 0.00
Net Debt to EBITDA		 -0.79 -0.74 -1.00 -0.89 -1.04 -1.25 -1.00 -1.15 -1.61 0.00 0.00
Long-Term Debt to EBITDA		 0.04 0.04 0.04 0.02 0.02 0.02 0.02 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.41 0.34 0.28 0.15 0.07 0.08 0.09 0.08 0.29 0.00 0.00
Net Debt to NOPAT		 -1.70 -1.54 -2.09 -1.83 -2.01 -2.63 -2.20 -3.16 -10.70 0.00 0.00
Long-Term Debt to NOPAT		 0.08 0.09 0.09 0.04 0.03 0.04 0.05 0.00 0.00 0.00 0.00
Altman Z-Score		 3.84 4.04 3.87 3.99 3.75 3.73 3.68 3.11 2.64 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.96 0.87 0.88 0.88 0.99 0.97 0.90 0.84 0.82 0.63 0.66
Quick Ratio		 0.79 0.70 0.71 0.71 0.83 0.80 0.70 0.63 0.64 0.42 0.44
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -5.50 5.56 13 11 24 15 0.04 4.20 4.38 7.20 4.83
Operating Cash Flow to CapEx		 1,009.38% 1,626.68% 1,983.54% 906.10% 2,032.71% 1,417.33% -107.54% 352.05% 236.45% 0.00% 97.23%
Free Cash Flow to Firm to Interest Expense		 -13.42 16.31 39.49 44.73 116.38 83.17 0.29 31.15 45.63 78.31 89.47
Operating Cash Flow to Interest Expense		 23.88 51.14 38.95 33.09 107.74 79.47 -8.78 46.39 103.52 0.00 20.83
Operating Cash Flow Less CapEx to Interest Expense		 21.51 47.99 36.98 29.44 102.44 73.86 -16.94 33.21 59.74 0.00 -0.59
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.11 1.23 1.22 1.28 1.13 1.26 1.29 1.27 1.06 0.00 0.00
Accounts Receivable Turnover		 3.63 4.77 5.03 4.85 3.42 4.75 5.18 5.08 3.46 0.00 0.00
Inventory Turnover		 17.32 17.52 17.34 14.41 16.11 16.72 15.87 14.80 13.85 0.00 0.00
Fixed Asset Turnover		 28.28 29.45 30.08 30.67 30.60 31.55 31.34 30.27 23.16 0.00 0.00
Accounts Payable Turnover		 7.72 10.61 8.19 10.00 9.21 11.42 9.06 10.38 7.63 0.00 0.00
Days Sales Outstanding (DSO)		 100.51 76.52 72.50 75.26 106.70 76.87 70.42 71.88 105.52 0.00 0.00
Days Inventory Outstanding (DIO)		 21.07 20.83 21.04 25.32 22.66 21.83 22.99 24.66 26.35 0.00 0.00
Days Payable Outstanding (DPO)		 47.28 34.41 44.54 36.51 39.62 31.95 40.30 35.18 47.83 0.00 0.00
Cash Conversion Cycle (CCC)		 74.31 62.94 49.00 64.07 89.74 66.75 53.12 61.37 84.04 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 48 43 35 38 36 29 34 33 36 25 31
Invested Capital Turnover		 6.74 6.50 6.83 6.84 6.85 8.04 8.34 7.87 7.41 0.00 0.00
Increase / (Decrease) in Invested Capital		 12 -0.66 -12 -5.34 -12 -14 -1.06 -5.75 -0.05 -8.60 -1.72
Enterprise Value (EV)		 533 494 471 457 480 428 383 271 216 138 255
Market Capitalization		 563 522 507 491 527 480 422 304 247 150 267
Book Value per Share		 $5.96 $5.25 $5.33 $5.44 $6.35 $6.12 $5.50 $5.05 $5.29 $3.29 $3.81
Tangible Book Value per Share		 $0.52 ($0.01) $0.09 $0.16 $1.08 $0.93 $0.40 ($0.10) $0.09 ($2.22) ($1.79)
Total Capital		 86 77 76 75 85 82 74 66 68 39 43
Total Debt		 7.37 6.14 4.91 2.85 1.61 1.62 1.64 0.82 0.82 0.84 0.00
Total Long-Term Debt		 1.54 1.56 1.58 0.76 0.78 0.79 0.80 0.00 0.00 0.00 0.00
Net Debt		 -31 -28 -36 -34 -47 -52 -39 -33 -31 -13 -12
Capital Expenditures (CapEx)		 0.97 1.07 0.64 0.90 1.08 1.00 1.27 1.78 4.20 0.00 1.16
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -39 -47 -54 -51 -50 -57 -53 -54 -59 -70 -60
Debt-free Net Working Capital (DFNWC)		 -0.80 -13 -13 -14 -1.37 -3.92 -12 -20 -27 -56 -48
Net Working Capital (NWC)		 -6.63 -17 -16 -17 -2.20 -4.75 -13 -21 -28 -57 -48
Net Nonoperating Expense (NNE)		 0.08 0.05 0.02 -0.01 -0.04 -0.08 0.06 -0.13 -0.04 0.58 0.02
Net Nonoperating Obligations (NNO)		 -31 -28 -36 -34 -47 -52 -39 -33 -31 -13 -12
Total Depreciation and Amortization (D&A)		 3.11 3.05 3.00 3.08 2.95 3.24 3.38 3.31 3.57 1.81 3.55
Debt-free, Cash-free Net Working Capital to Revenue		 -13.91% -16.75% -19.20% -18.16% -17.42% -19.87% -18.38% -19.36% -21.98% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 -0.28% -4.60% -4.55% -5.15% -0.48% -1.36% -4.26% -7.32% -10.11% 0.00% 0.00%
Net Working Capital to Revenue		 -2.36% -6.24% -5.74% -5.89% -0.77% -1.65% -4.55% -7.61% -10.42% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.50 $0.37 $0.07 $0.43 $0.91 $0.09 ($0.08) ($0.11) $0.34 ($0.17) $0.27
Adjusted Weighted Average Basic Shares Outstanding		 13.64M 13.24M 13.26M 13.16M 13.17M 13.09M 13.10M 12.89M 12.93M 11.42M 11.26M
Adjusted Diluted Earnings per Share		 $0.48 $0.36 $0.06 $0.43 $0.89 $0.09 ($0.08) ($0.11) $0.34 ($0.17) $0.27
Adjusted Weighted Average Diluted Shares Outstanding		 14.30M 13.64M 13.48M 13.38M 13.47M 13.27M 13.10M 12.89M 13.05M 11.42M 11.45M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.43M 13.29M 13.27M 13.09M 13.18M 13.20M 12.99M 12.64M 12.16M 11.27M 11.29M
Normalized Net Operating Profit after Tax (NOPAT)		 6.89 5.43 2.53 6.19 12 2.57 -1.02 1.78 4.33 -0.34 3.62
Normalized NOPAT Margin		 8.84% 7.94% 4.12% 8.43% 14.16% 3.73% -1.71% 2.64% 6.08% -0.57% 5.34%
Pre Tax Income Margin		 13.40% 7.71% 2.31% 11.40% 21.39% 2.30% -2.26% -3.17% 11.17% -3.46% 6.14%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 25.78 15.63 4.40 33.78 88.32 8.29 -9.33 -16.32 82.16 -21.73 77.70
NOPAT to Interest Expense		 16.81 14.37 2.72 23.10 58.69 6.17 -6.53 -11.42 45.15 -15.21 57.54
EBIT Less CapEx to Interest Expense		 23.41 12.48 2.43 30.13 83.01 2.68 -17.49 -29.50 38.38 0.00 56.28
NOPAT Less CapEx to Interest Expense		 14.45 11.23 0.75 19.45 53.39 0.56 -14.69 -24.60 1.37 0.00 36.12
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 199.96% 284.04% 288.32% 173.77% 131.39% 103.36% 151.81% 261.89% 859.65% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Franklin Covey’s latest quarter shows a sharp reversal from profitability to a modest loss, driven by weaker revenue, higher operating costs, and a large restructuring charge. In fiscal Q2 2026, revenue fell to $59.6 million from $71.2 million in Q4 2025 and $61.3 million in Q2 2025, while the company posted an operating loss of $2.0 million and net loss attributable to common shareholders of $1.9 million. That’s a meaningful step down from the strong profit generated in the prior quarter.

What stands out most is that the business is still generating cash, even as earnings turned negative. Operating cash flow was $9.9 million in Q4 2025 and remained positive at $14.1 million in Q1 2025, but in the latest quarter cash and equivalents declined to $13.7 million from $17.5 million at the end of Q1 2025, reflecting seasonal working-capital pressure and continued investment outflows.

  • Operating cash flow has remained positive in several recent quarters, including $9.9 million in Q4 2025 and $14.1 million in Q1 2025, showing the underlying business can still generate cash.
  • The company ended Q2 2026 with no long-term debt, which reduces financial risk and interest burden.
  • Cash income tax and interest payments remain manageable relative to operating cash flow, suggesting the current capital structure is not overly stressed.
  • Gross profit in Q2 2026 was still strong at $45.3 million, implying the core business retains solid gross margin economics.
  • Revenue has been relatively stable over the long term, but recent quarterly comparisons show some volatility rather than a clear growth trend.
  • The balance sheet remains asset-heavy, with significant deferred revenue, accounts receivable, and intangible assets.
  • Share count has fluctuated over time, and the company continues to repurchase shares in some quarters, which can affect per-share results.
  • Revenue declined to $59.6 million in Q2 2026 from $71.2 million in Q4 2025, indicating a softer sales environment.
  • Operating expenses were higher than gross profit in Q2 2026, producing an operating loss of $2.0 million.
  • The latest quarter included a $1.5 million restructuring charge, which weighed on results.
  • Net income attributable to common shareholders was a loss of $1.9 million, versus a profit of $4.2 million in Q4 2025 and $979,000 in Q1 2025.
  • Cash and equivalents fell to $13.7 million from $17.5 million in Q1 2025, showing less liquidity cushion than earlier in the year.

Looking at the broader 2024–2026 trend, Franklin Covey appears to be a company with decent gross profitability and cash generation, but inconsistent bottom-line performance. The recent swing back to losses suggests operating leverage is not yet stable enough to absorb revenue softness or one-time charges. For retail investors, the key question is whether management can restore revenue growth while keeping SG&A and restructuring-related costs under control.

Bottom line: FC’s financial position is not distressed, thanks to positive cash flow and no long-term debt, but the latest quarter shows clear earnings pressure. Investors should watch for stabilization in revenue, a reduction in restructuring charges, and a return to positive operating income in upcoming quarters.

07/14/26 02:15 AM ETAI Generated. May Contain Errors.

Franklin Covey Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Franklin Covey's financial year ends in August. Their financial year 2025 ended on August 31, 2025.

Franklin Covey's net income appears to be on an upward trend, with a most recent value of $3.07 million in 2025, falling from $11.12 million in 2015. The previous period was $23.40 million in 2024. See Franklin Covey's forecast for analyst expectations on what's next for the company.

Franklin Covey's total operating income in 2025 was $5.70 million, based on the following breakdown:
  • Total Gross Profit: $203.57 million
  • Total Operating Expenses: $197.87 million

Over the last 10 years, Franklin Covey's total revenue changed from $209.94 million in 2015 to $267.07 million in 2025, a change of 27.2%.

Franklin Covey's total liabilities were at $176.00 million at the end of 2025, a 1.3% decrease from 2024, and a 134.2% increase since 2015.

In the past 10 years, Franklin Covey's cash and equivalents has ranged from $8.92 million in 2017 to $60.52 million in 2022, and is currently $31.70 million as of their latest financial filing in 2025.

Over the last 10 years, Franklin Covey's book value per share changed from 7.58 in 2015 to 5.29 in 2025, a change of -30.1%.


Related Companies

Financial statements for NYSE:FC last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
They told you not to miss this one
The largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the abs...
Thor Metals | Sponsoredtc pixel
Forget SpaceX, this is Elon’s Next Breakthrough
Jeff Brown and Marc Chaikin - two investors who called Nvidia a decade ago - say Elon Musk's newly filed AI pa...
Brownstone Research | Sponsoredtc pixel
When I found Rolls-Royce under $2, most people thought I was crazy
In 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...
Monument Traders Alliance | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel